Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Development of T-Cell Therapy By Exploiting Modified Antibodies Specific for A2/NY-ESO-1 for Refractory Myeloma

Masaki Maruta, MD, Toshiki Ochi, MD PhD, Kazushi Tanimoto, MD PhD, Taichi Azuma, MD PhD, Hiroshi Fujiwara, MD PhD, Masaki Yasukawa, MD PhD

Blood (2017) 130 (Supplement 1): 1913.

https://doi.org/10.1182/blood.V130.Suppl_1.1913.1913

Published: 2017

Journal Articles

Clinical Outcomes of Patients with Primary Myelofibrosis in Japan: A Nationwide Survey over a 17-Year Study Period

Katsuto Takenaka, MD PhD, Kazuya Shimoda, MD, PhD, Naoyuki Uchida, MDPhD, Taizo Shimomura, MD PhD, Koji Nagafuji, MD PhD, Tadakazu Kondo, MD PhD, Hirohiko Shibayama, MDPhD, Takehiko Mori, MD PhD, Kensuke Usuki, MD PhD, Taichi Azuma, MDPhD, Yutaka Tsutsumi, MD PhD, Junji Tanaka, MD PhD, Hitomi Dairaku, Keitaro Matsuo, MDPhD, Keiya Ozawa, MD PhD, Mineo Kurokawa, MD, PhD, Shunya Arai, MD, PhD, Koichi Akashi, MD PhD

Blood (2016) 128 (22): 3126.

https://doi.org/10.1182/blood.V128.22.3126.3126

Published: 2016

Journal Articles

Function of Integrin αIIbβ3 in Essential Thrombocythemia with Calreticulin Mutation

Jun Yamanouchi, MD PhD, Takaaki Hato, MDPhD, Etsuko Matsubara, MDPhD, Taichi Azuma, MDPhD, Hiroshi Fujiwara, MD PhD, Yoshihiro Yakushijin, MDPhD, Masaki Yasukawa, MD PhD

Blood (2015) 126 (23): 4079.

https://doi.org/10.1182/blood.V126.23.4079.4079

Published: 2015

Journal Articles

Activation Status of Integrin αIIbβ3 in Essential Thrombocythemia with Calreticulin Mutation

Jun Yamanouchi, MD PhD, Takaaki Hato, MDPhD, Etsuko Matsubara, MDPhD, Taichi Azuma, MDPhD, Hideyuki Nakanishi, MD, Hiroshi Fujiwara, MD PhD, Yoshihiro Yakushijin, MDPhD, Masaki Yasukawa, MD PhD

Blood (2014) 124 (21): 4571.

https://doi.org/10.1182/blood.V124.21.4571.4571

Published: 2014

Journal Articles

The Efficacy and Long-Term Outcomes of ASCT in POEMS Syndrome: A Multicenter Retrospective Study in Japan

Chika Kawajiri, MD, Emiko Sakaida, MD PhD, Chikako Ohwada, MD PhD, Toshihiro Miyamoto, MD PhD, Taichi Azuma, MDPhD, Jun Taguchi, MD PhD, Takehiko Mori, MD PhD, Yuichi Hasegawa, MD PhD, Tadakazu Kondo, MD PhD, Toshiaki Yujiri, MD PhD, Makoto Yoshimitsu, MDPhD, Mitsuru Tsudo, Toshihiko Iwasaki, MD PhD, Akio Shigematsu, MD PhD, Ritsuro Suzuki, MD PhD, Yoshiko Atsuta, MDPhD, Makoto Hirokawa, MD PhD, Hisashi Sakamaki, MDPhD, Chiaki Nakaseko, MD PhD

Blood (2014) 124 (21): 3970.

https://doi.org/10.1182/blood.V124.21.3970.3970

Published: 2014

Journal Articles

Co-Administration Of Gene-Modified CD4 + T Cells Targeting HLA Class I-Restricted WT1 Epitope Diversely Enhances The Antitumor Effect Mediated By Redirected T-Cell Based Adoptive Immunotherapy Against Human Leukemia

Hiroshi Fujiwara, MD, PhD, Fumihiro Ochi, MD, Toshiki Ochi, MD, PhD, Hiroaki Asai, MD, PhD, Yukihiro Miyazaki, MD, PhD, Taichi Azuma, MD, PhD, Sachiko Okamoto, PhD, Junichi Mineno, PhD, Miwako Narita, MD, PhD, Kiyotaka Kuzushima, MD, PhD, Hiroshi Shiku, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2013) 122 (21): 144.

https://doi.org/10.1182/blood.V122.21.144.144

Published: 2013

Journal Articles

Development of a novel redirected T-cell–based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia

Yukihiro Miyazaki, Hiroshi Fujiwara, Hiroaki Asai, Fumihiro Ochi, Toshiki Ochi, Taichi Azuma, Takashi Ishida, Sachiko Okamoto, Junichi Mineno, Kiyotaka Kuzushima, Hiroshi Shiku, Masaki Yasukawa

Blood (2013) 121 (24): 4894–4901.

https://doi.org/10.1182/blood-2012-11-465971

Published: 2013

Includes: Supplemental data

Journal Articles

The Role of Activation-Induced Cytidine Deaminase (AID/AICDA) in the Progression of Follicular Lymphoma

Hisaharu Shikata, Yoshihiro Yakushijin, MD, PhD, Natsuki Matsushita, Akira Sakai, MD, PhD, Atsuro Sugita, Naoya Nakamura, MD, PhD, Jun Yamanouchi, MD, PhD, Taichi Azuma, Takaaki Hato, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2011) 118 (21): 5234.

https://doi.org/10.1182/blood.V118.21.5234.5234

Published: 2011

Journal Articles

Aurora-A kinase: a novel target of cellular immunotherapy for leukemia

Toshiki Ochi, Hiroshi Fujiwara, Koichiro Suemori, Taichi Azuma, Yoshihiro Yakushijin, Takaaki Hato, Kiyotaka Kuzushima, Masaki Yasukawa

Blood (2009) 113 (1): 66–74.

https://doi.org/10.1182/blood-2008-06-164889

Published: 2009

Includes: Supplemental data

Journal Articles

Aurora-a Kinase: A Novel Target of Cellular Immunotherapy for Human Leukemia

Toshiki Ochi, MD, Hiroshi Fujiwara, MD, PhD, Koichiro Suemori, MD, Taichi Azuma, MD, PhD, Kiyotaka Kuzushima, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2008) 112 (11): 2904.

https://doi.org/10.1182/blood.V112.11.2904.2904

Published: 2008

Journal Articles

Aurora-A Kinase: A Novel Target for the Immunotherapy Against Human Leukemias.

Toshiki Ochi, MD, Hiroshi Fujiwara, MD., PhD, Kohichiro Suemori, MD, Taichi Azuma, MD., PhD, Kiyotaka Kuzushima, MD., PhD, Masaki Yasukawa, MD., PhD

Blood (2007) 110 (11): 1796.

https://doi.org/10.1182/blood.V110.11.1796.1796

Published: 2007

Journal Articles

The Role of EHZF in Erythroid Differentiation of K562 Cells.

Etsuko Matsubara, Ikuya Sakai, MD, Jun Yamanouchi, MD, Taichi Azuma, MD, Hiroshi Narumi, MD, Takaaki Hato, MD, Hitoshi Hasegawa, MD, Masaki Yasukawa, MD

Blood (2006) 108 (11): 1311.

https://doi.org/10.1182/blood.V108.11.1311.1311

Published: 2006

Journal Articles

Absence of Chlamydial Infection in Japanese Patients with Ocular Adnexal MALT Lymphoma.

Yoshihiro Yakushijin, MD, PhD, Toshio Kodama, MD, PhD, Ikue Takaoka, Kazushi Tanimoto, MD, Hiroko Bessho, PhD, Jun Yamanouchi, MD, PhD, Taichi Azuma, MD, PhD, Hiroshi Narumi, MD, PhD, Takaaki Hato, MD, PhD, Hitoshi Hasegawa, MD, PhD, Masaki Yasukawa, MD, PhD

Blood (2006) 108 (11): 4626.

https://doi.org/10.1182/blood.V108.11.4626.4626

Published: 2006

Journal Articles

Direct recognition and lysis of leukemia cells by WT1-specific CD4 + T lymphocytes in an HLA class II-restricted manner

Yun Guo, Hironari Niiya, Taichi Azuma, Naoyuki Uchida, Yoshihiro Yakushijin, Ikuya Sakai, Takaaki Hato, Masuhiro Takahashi, Satoru Senju, Yasuharu Nishimura, Masaki Yasukawa

Blood (2005) 106 (4): 1415–1418.

https://doi.org/10.1182/blood-2005-01-0413

Published: 2005

Journal Articles

Generation of tumor-specific, HLA class I–restricted human Th1 and Tc1 cells by cell engineering with tumor peptide–specific T-cell receptor genes

Takemasa Tsuji, Masaki Yasukawa, Junko Matsuzaki, Takayuki Ohkuri, Kenji Chamoto, Daiko Wakita, Taichi Azuma, Hironari Niiya, Hiroyuki Miyoshi, Kiyotaka Kuzushima, Yoshihiro Oka, Haruo Sugiyama, Hiroaki Ikeda, Takashi Nishimura

Blood (2005) 106 (2): 470–476.

https://doi.org/10.1182/blood-2004-09-3663

Published: 2005

Journal Articles

Differential Regulation of Perforin Expression in CD4 + and CD8 + Cytotoxic T Lymphocytes.

Hironari Niiya, M.D., Jin Lei, M.D., Ikuya Sakai, M.D., Ph.D., Taichi Azuma, M.D., Naoyuki Uchida, M.D., Ph.D., Yoshihiro Yakushijin, M.D., Ph.D., Takaaki Hato, M.D., Ph.D., Shigeru Fujita, M.D., Ph.D., Masaki Yasukawa, M.D., Ph.D.

Blood (2004) 104 (11): 3848.

https://doi.org/10.1182/blood.V104.11.3848.3848

Published: 2004

Journal Articles

Generation of Tumor-Specific CD8 + Cytotoxic T Lymphocytes and CD4 + Th1 Helper T Cells by Transfer of T-Cell Receptor Genes Isolated from a WT1-Specific CD8 + Cytotoxic T-Lymphocyte Clone.

Masaki Yasukawa, M.D., Ph.D., Hironari Niiya, M.D., Taichi Azuma, M.D., Naoyuki Uchida, M.D., Ph.D., Yoshihiro Yakushijin, M.D., Ph.D., Ikuya Sakai, M.D., Ph.D., Takaaki Hato, M.D., Ph.D., Shigeru Fujita, M.D., Ph.D., Takemasa Tsuji, Ph.D., Takashi Nishimura, M.D., Ph.D.

Blood (2004) 104 (11): 2523.

https://doi.org/10.1182/blood.V104.11.2523.2523

Published: 2004

NARROW

Development of T-Cell Therapy By Exploiting Modified Antibodies Specific for A2/NY-ESO-1 for Refractory Myeloma

Clinical Outcomes of Patients with Primary Myelofibrosis in Japan: A Nationwide Survey over a 17-Year Study Period

Function of Integrin αIIbβ3 in Essential Thrombocythemia with Calreticulin Mutation

Activation Status of Integrin αIIbβ3 in Essential Thrombocythemia with Calreticulin Mutation

The Efficacy and Long-Term Outcomes of ASCT in POEMS Syndrome: A Multicenter Retrospective Study in Japan

Co-Administration Of Gene-Modified CD4 + T Cells Targeting HLA Class I-Restricted WT1 Epitope Diversely Enhances The Antitumor Effect Mediated By Redirected T-Cell Based Adoptive Immunotherapy Against Human Leukemia

Development of a novel redirected T-cell–based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia

The Role of Activation-Induced Cytidine Deaminase (AID/AICDA) in the Progression of Follicular Lymphoma

Aurora-A kinase: a novel target of cellular immunotherapy for leukemia

Aurora-a Kinase: A Novel Target of Cellular Immunotherapy for Human Leukemia

Aurora-A Kinase: A Novel Target for the Immunotherapy Against Human Leukemias.

The Role of EHZF in Erythroid Differentiation of K562 Cells.

Absence of Chlamydial Infection in Japanese Patients with Ocular Adnexal MALT Lymphoma.

Direct recognition and lysis of leukemia cells by WT1-specific CD4 + T lymphocytes in an HLA class II-restricted manner

Generation of tumor-specific, HLA class I–restricted human Th1 and Tc1 cells by cell engineering with tumor peptide–specific T-cell receptor genes

Differential Regulation of Perforin Expression in CD4 + and CD8 + Cytotoxic T Lymphocytes.

Generation of Tumor-Specific CD8 + Cytotoxic T Lymphocytes and CD4 + Th1 Helper T Cells by Transfer of T-Cell Receptor Genes Isolated from a WT1-Specific CD8 + Cytotoxic T-Lymphocyte Clone.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only